Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Tulasne

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Nature Communications|March 22, 2020
2,6-Diaminopurine as a highly potent corrector of UGA nonsense mutationsCarole Trzaska, Séverine Amand, Christine Bailly, et al.
Molecular Cancer Therapeutics|March 31, 2019
Functional Analysis of Somatic Mutations Affecting Receptor Tyrosine Kinase Family in Metastatic Colorectal CancerLeslie Duplaquet, Martin Figeac, Frédéric Leprêtre, et al.
Molecular Oncology|February 17, 2023
MET exon 14 skipping mutation is a hepatocyte growth factor (HGF)-dependent oncogenic driver in vitro and in humanised HGF knock-in miceMarie Fernandes, Brynna Hoggard, Philippe Jamme, et al.
Plos Biology|December 12, 2025
Derepression of the epithelial transcription factor GRHL2 promotes direct hepatocyte-to-cholangiocyte transdifferentiationLudivine Vasseur, Céline Gheeraert, Julie Dubois-Chevalier, et al.
Human Mutation|December 9, 2021
Novel germline MET pathogenic variants in French patients with papillary renal cell carcinomas type IMolka Sebai, David Tulasne, Sandrine M Caputo, et al.
Nature Communications|August 22, 2025
Prolonging lung cancer response to EGFR inhibition by targeting the selective advantage of resistant cellsLisa Brunet, David Alexandre, Jiyoung Lee, et al.
Ebiomedicine|June 23, 2016
ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's DiseaseFlorent Letronne, Geoffroy Laumet, Anne-Marie Ayral, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Nature Communications|March 22, 2020
2,6-Diaminopurine as a highly potent corrector of UGA nonsense mutationsCarole Trzaska, Séverine Amand, Christine Bailly, et al.
Molecular Cancer Therapeutics|March 31, 2019
Functional Analysis of Somatic Mutations Affecting Receptor Tyrosine Kinase Family in Metastatic Colorectal CancerLeslie Duplaquet, Martin Figeac, Frédéric Leprêtre, et al.
Molecular Oncology|February 17, 2023
MET exon 14 skipping mutation is a hepatocyte growth factor (HGF)-dependent oncogenic driver in vitro and in humanised HGF knock-in miceMarie Fernandes, Brynna Hoggard, Philippe Jamme, et al.
Plos Biology|December 12, 2025
Derepression of the epithelial transcription factor GRHL2 promotes direct hepatocyte-to-cholangiocyte transdifferentiationLudivine Vasseur, Céline Gheeraert, Julie Dubois-Chevalier, et al.
Human Mutation|December 9, 2021
Novel germline MET pathogenic variants in French patients with papillary renal cell carcinomas type IMolka Sebai, David Tulasne, Sandrine M Caputo, et al.
Nature Communications|August 22, 2025
Prolonging lung cancer response to EGFR inhibition by targeting the selective advantage of resistant cellsLisa Brunet, David Alexandre, Jiyoung Lee, et al.
Ebiomedicine|June 23, 2016
ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's DiseaseFlorent Letronne, Geoffroy Laumet, Anne-Marie Ayral, et al.
Pageof 7